Clinical trial

Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - B

NCT02811731

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-04-01

PhasePHASE1

Study timeline

Study start (unknown)2015-04-01Date precision: month

Registry last updated2016-06-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensionunresolved

Interventions

CKD-330 16/5mg - BDRUG

Candesartan 16mg and Amlodipine 5mgDRUG

Sponsors & collaborators

Chong Kun Dang Pharmaceuticallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02811731 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.